EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Study Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM)

May Lee Tjoa, Ashley Orillion, Raymond Mankoski, Nida Imran, Carol Mao, Alexis Krumme, Sylvie Van Hoorde, Blanca Linares-Rivas Rico, Yosuke Komatsu

American Journal of Perinatology · 2026-10 · 43 (13) · 1731-1738

DOI: 10.1055/a-2816-3361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, online erschienen am 20.03.2026. Verfasst von May Lee Tjoa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Johnson & Johnson, Cambridge, Massachusetts, United States. Hauptthemen laut MEDLINE: Erythroblastosis, Fetal, Immunoglobulins, Intravenous, Registries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemolytic disease of the fetus and newborn (HDFN) is a rare and serious immune-mediated condition that can result in poor fetal and neonatal outcomes. During pregnancy, monitoring with middle cerebral artery Doppler ultrasound and intrauterine transfusions (IUTs) are the current standard of care, although intravenous immunoglobulin (IVIg) has been adopted in some centers to attempt to delay the onset of fetal anemia. Significant gaps remain in understanding the safety and effectiveness of current HDFN management, both during pregnancy and in neonates and children. We present the design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM; ClinicalTrials.gov Identifier: NCT07194070), a study that will provide real-world, prospective, longitudinal data on management, clinical course, and outcomes of HDFN from the antenatal period up to 2 years after birth. GERANIUM is a prospective, observational study enrolling alloimmunized pregnant individuals (aged ≥18 years) before 24 weeks of gestational age who are at high risk for HDFN based on previous obstetric history. This study will enroll approximately 175 participants across multiple global sites. Data collected during pregnancy include fetal loss, frequency and severity of HDFN, treatment patterns, as well as effectiveness and adverse outcomes of IUTs and other interventions. Following birth, infants will be followed for the first 2 years of life, with documentation of HDFN sequelae, including treatments, growth, and development. Impact on the parents and children will be assessed using validated participant- and observer-reported outcome measures. The GERANIUM registry will provide prospective, contemporaneous data on current management of HDFN and associated outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erythroblastosis, FetalImmunoglobulins, IntravenousRegistriesFemaleHumansInfant, NewbornPregnancyBlood Transfusion, IntrauterineMiddle Cerebral ArteryProspective StudiesResearch DesignObservational Studies as Topic

Substanzen

Immunoglobulins, Intravenous

Autor:innen und Institutionen

  • Johnson & Johnson, Cambridge, Massachusetts, United States.
  • Johnson & Johnson, Horsham, Pennsylvania, United States.
  • The NemetzGroup, Boston, Massachusetts, United States.
  • Johnson & Johnson, Beerse, Belgium.
  • Johnson & Johnson, Madrid, Spain.
  • Johnson & Johnson, Spring House, Pennsylvania, United States.

Zitieren

APA

Tjoa, M. L., Orillion, A., Mankoski, R., Imran, N., Mao, C., Krumme, A., Van Hoorde, S., Linares-Rivas Rico, B., & Komatsu, Y. (2026). Study Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM). American Journal of Perinatology, 43(13), 1731-1738. https://doi.org/10.1055/a-2816-3361

Vancouver

Tjoa ML, Orillion A, Mankoski R, Imran N, Mao C, Krumme A, et al. Study Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM). American Journal of Perinatology. 2026;43(13):1731-1738. doi:10.1055/a-2816-3361

BibTeX
@article{Tjoa2026,
  author = {Tjoa, May Lee and Orillion, Ashley and Mankoski, Raymond and Imran, Nida and Mao, Carol and Krumme, Alexis and Van Hoorde, Sylvie and Linares-Rivas Rico, Blanca and Komatsu, Yosuke},
  title = {Study Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM)},
  journal = {American Journal of Perinatology},
  year = {2026},
  volume = {43},
  number = {13},
  pages = {1731--1738},
  doi = {10.1055/a-2816-3361}
}
Kostenlos starten →